Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosis

in European Journal of Endocrinology
Correspondence should be addressed to P Touraine; Email: philippe.touraine@aphp.fr
Restricted access

Objective

Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasm which can infiltrate any organ or tissue. Endocrine involvement has mostly been described in case reports and small retrospective studies. We aimed to describe endocrine manifestations in a large cohort of adulthood onset (AO) and childhood onset (CO) patients with LCH.

Design

Single-center observational study conducted between January 2002 and December 2017 at Pitié-Salpêtrière University Hospital (Paris, France), a tertiary care hospital.

Method

Clinical, biological and morphological evaluations of pituitary, gonadal, adrenal and thyroid function evaluations performed in 63 consecutive patients with LCH (AO patients: 40, CO patients: 23). Fifty-eight patients underwent follow-up assessments.

Results

Complete pituitary evaluation was performed in 38/63 patients (60.3%); at least one anterior pituitary dysfunction (APD) was found in 63.2% of them. In this subgroup of patients, the most prevalent deficiencies were diabetes insipidus (DI) and GHD (55.3% each), followed by gonadotropin deficiency (34.2%) and thyrotropin deficiency (23.7%). In the subgroup of the 25 incompletely evaluated patients, we found DI in 44%, GHD in 50%, gonadotropin deficiency in 30.4% and thyrotropin deficiency in 16%. APD was more common in CO patients (P = 0.003) but was not systematically associated with DI regardless of the age of onset. Endocrine dysfunction was most often permanent; moreover, occurrence of new deficiencies has been described during follow-up.

Conclusion

The spectrum of endocrine disorders appears to be large in LCH (both in AO and CO patients) and should be evaluated carefully at diagnosis and during follow-up. APD was not always associated with DI.

 

     European Society of Endocrinology

Related Articles

Article Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 285 285 174
Full Text Views 40 40 23
PDF Downloads 26 26 16

Altmetrics

Figures

  • View in gallery

    Flow chart to indicate how subjects were selected for inclusion in the study. APD, anterior pituitary deficiency; DI, diabetes insipidus; LCH, Langerhans cell histiocytosis.

References

  • 1

    GirschikofskyMAricoMCastilloDChuADoberauerCFichterJHarocheJKaltsasGAMakrasPMarzanoAV Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet Journal of Rare Diseases 2013 8 72. (https://doi.org/10.1186/1750-1172-8-72)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    HauptRMinkovMAstigarragaISchäferENanduriVJubranREgelerRMJankaGMicicDRodriguez-GalindoC et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatric Blood and Cancer 2013 60 175184. (https://doi.org/10.1002/pbc.24367)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    BerresM-LMeradMAllenCE. Progress in understanding the pathogenesis of langerhans cell histiocytosis: back to histiocytosis X? British Journal of Haematology 2015 169 313. (https://doi.org/10.1111/bjh.13247)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    LaurencikasEGavhedDStålemarkHvan’t HooftIPrayerDGroisNHenterJ-I. Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study. Pediatric Blood and Cancer 2011 56 250257. (https://doi.org/10.1002/pbc.22791)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5

    EmileJFCharlotteFChassagne-ClementCCopinMCFraitagSMokhtariKMoreauA. Classification histologique et altérations moléculaires des histiocytoses. Presse Médicale 2017 46 4654. (https://doi.org/10.1016/j.lpm.2016.01.016)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    VassalloRHarariSTaziA. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax 2017 72 937945. (https://doi.org/10.1136/thoraxjnl-2017-210125)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    EmileJFAblaOFraitagSHorneAHarocheJDonadieuJRequena-CaballeroLJordanMBAbdel-WahabOAllenCE et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016 127 26722681. (https://doi.org/10.1182/blood-2016-01-690636)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    GadnerHMinkovMGroisNPotschgerUThiemEAricoMAstigarragaIBraierJDonadieuJHenterJI et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood 2013 121 50065014. (https://doi.org/10.1182/blood-2012-09-455774)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    MakrasPAlexandrakiKIChrousosGPGrossmanABKaltsasGA. Endocrine manifestations in Langerhans cell histiocytosis. Trends in Endocrinology and Metabolism 2007 18 252257. (https://doi.org/10.1016/j.tem.2007.06.003)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    MontefuscoLHarariSEliaDRossiASpecchiaCTorreOAddaGArosioM. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis. European Journal of Internal Medicine 2018 51 6167. (https://doi.org/10.1016/j.ejim.2017.11.011)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    RigaudCBarkaouiMAThomasCBertrandYLambilliotteAMironJAladjidiNPlatGJeziorskiEGalambrunC Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age. British Journal of Haematology 2016 174 887898. (https://doi.org/10.1111/bjh.14140)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    GarrahyAMoranCThompsonCJ. Diagnosis and management of central diabetes insipidus in adults. Clinical Endocrinology 2019 90 2330. (https://doi.org/10.1111/cen.13866)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    FleseriuMHashimIAKaravitakiNMelmedSMuradMHSalvatoriRSamuelsMH. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2016 101 38883921. (https://doi.org/10.1210/jc.2016-2118)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14

    ChahalJSchlechteJ. Hyperprolactinemia. Pituitary 2008 11 141146. (https://doi.org/10.1007/s11102-008-0107-5)

  • 15

    ChitaleAMusondaPMcGregorAMDhatariyaKK. Determining the utility of the 60 min cortisol measurement in the short synacthen test. Clinical Endocrinology 2013 79 1419. (https://doi.org/10.1111/j.1365-2265.2012.04478.x)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    BornsteinSRAllolioBArltWBarthelADon-WauchopeAHammerGDHusebyeESMerkeDPMuradMHStratakisCA Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2016 101 364389. (https://doi.org/10.1210/jc.2015-1710)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    MolitchMEClemmonsDRMalozowskiSMerriamGRVanceML & Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011 96 15871609. (https://doi.org/10.1210/jc.2011-0179)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    HoKKY & 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695700. (https://doi.org/10.1530/EJE-07-0631)

    • Search Google Scholar
    • Export Citation
  • 19

    YuenKCJ. Growth hormone stimulation tests in assessing adult growth hormone deficiency. In Endotext. Eds FeingoldKRAnawaltBBoyceAChrousosGDunganKGrossmanAHershmanJMKaltsasGKochCKoppP et al. South Dartmouth, MA, USA: MDText.com, Inc.2000. (available at http://www.ncbi.nlm.nih.gov/books/NBK395585/)

    • Search Google Scholar
    • Export Citation
  • 20

    BozzolaMMeazzaC. Growth hormone deficiency: diagnosis and therapy in children. In Restricted Growth – Clinical Genetic and Molecular Aspects. Ed Cardenas-AguayoM del C. London, UK: InTech2016. (https://doi.org/10.5772/64803)

    • Search Google Scholar
    • Export Citation
  • 21

    WagnerIVPaetzoldCGauscheRVogelMKoernerAThieryJArseneCGHenrionAGuettlerBKellerE Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. European Journal of Endocrinology 2014 171 389397. (https://doi.org/10.1530/EJE-14-0165)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    ClaytonPECuneoRCJuulAMonsonJPShaletSMTauberM & European Society of Paediatric Endocrinology. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. European Journal of Endocrinology 2005 152 165170. (https://doi.org/10.1530/eje.1.01829)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    SocietyGR. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology and Metabolism 2000 85 39903993. (https://doi.org/10.1210/jcem.85.11.6984)

    • Search Google Scholar
    • Export Citation
  • 24

    AlbertiCChevenneDMercatIJosserandEArmoogum-BoizeauPTichetJLegerJ. Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clinical Chemistry 2011 57 14241435. (https://doi.org/10.1373/clinchem.2011.169466)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    SchousboeJTShepherdJABilezikianJPBaimS. Executive summary of the 2013 International Society for clinical densitometry position development conference on bone densitometry. Journal of Clinical Densitometry 2013 16 455466. (https://doi.org/10.1016/j.jocd.2013.08.004)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    MakrasPKaltsasG. Langerhans cell histiocytosis and pituitary function. Endocrine 2015 48 728729. (https://doi.org/10.1007/s12020-014-0497-2)

  • 27

    García GalloMSMartínezMPAbalovichMSGutiérrezSGuitelmanMA. Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults. Pituitary 2010 13 298303. (https://doi.org/10.1007/s11102-010-0233-8)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    ImashukuS. Management of adult Langerhans cell histiocytosis based on the characteristic clinical features. World Journal of Hematology 2013 2 8998. (https://doi.org/10.5315/wjh.v2.i3.89)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29

    DonadieuJRolonMAThomasCBrugieresLPlantazDFrançois EmileJFFrappazDDavidMBraunerRGenereauT et al. Endocrine involvement in pediatric-onset Langerhans’ cell histiocytosis: a population-based study. Journal of Pediatrics 2004 144 344350. (https://doi.org/10.1016/j.jpeds.2003.12.030)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    TaziALorillonGHarocheJNeelADominiqueSAoubaABouazizJDde Margerie-MelonCBugnetECottinV Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Orphanet Journal of Rare Diseases 2017 12 95. (https://doi.org/10.1186/s13023-017-0651-z)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    MarchandIBarkaouiMAGarelCPolakMDonadieuJ & Writing Committee. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. Journal of Clinical Endocrinology and Metabolism 2011 96 E1352E1360. (https://doi.org/10.1210/jc.2011-0513)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    GroisNPötschgerUProschHMinkovMAricoMBraierJHenterJIJanka-SchaubGLadischSRitterJ et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatric Blood and Cancer 2006 46 228233. (https://doi.org/10.1002/pbc.20425)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    AricòMGirschikofskyMGénéreauTKlersyCMcClainKGroisNEmileJFLukinaEDe JuliEDanesinoC. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. European Journal of Cancer 2003 39 23412348. (https://doi.org/10.1016/S0959-8049(03)00672-5)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34

    KaltsasGAPowlesTBEvansonJPlowmanPNDrinkwaterJEJenkinsPJMonsonJPBesserGMGrossmanAB. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. Journal of Clinical Endocrinology and Metabolism 2000 85 13701376. (https://doi.org/10.1210/jcem.85.4.6501)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    CourtillotCLaugier RobiolleSCohen AubartFLebanMRenard-PennaRDrierACharlotteFAmouraZTourainePHarocheJ. Endocrine manifestations in a monocentric cohort of 64 patients with Erdheim-Chester disease. Journal of Clinical Endocrinology and Metabolism 2016 101 305313. (https://doi.org/10.1210/jc.2015-3357)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    PertuisetELaredoJDLiotéFWassefMJagueuxMKuntzD. Erdheim-Chester disease: report of a case, review of the literature and discussion of the relation to Langerhans-cell histiocytosis. Revue du Rhumatisme 1993 60 601609.

    • Search Google Scholar
    • Export Citation
  • 37

    ChowTWLeungWKChengFWTKumtaSMChuWCWLeeVShingMMKLiCK. Late outcomes in children with Langerhans cell histiocytosis. Archives of Disease in Childhood 2017 102 830835. (https://doi.org/10.1136/archdischild-2016-312185)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    VaranACilaAAkyuzCKaleGKutlukTBuyukpamukcuM. Radiological evaluation of patients with pituitary Langerhans cell histiocytosis at diagnosis and at follow-up. Pediatric Hematology and Oncology 2008 25 567574. (https://doi.org/10.1080/08880010802237112)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    KurtulmusNMertMTanakolRYarmanS. The pituitary gland in patients with Langerhans cell histiocytosis: a clinical and radiological evaluation. Endocrine 2015 48 949956. (https://doi.org/10.1007/s12020-014-0408-6)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    HéritierSBarkaouiMAMironJThomasCMoshousDLambilliotteAMazingueFKebailiKJeziorskiEPlatG Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study. British Journal of Haematology 2018 183 608617. (https://doi.org/10.1111/bjh.15577)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    HauptRNanduriVCalevoMGBernstrandCBraierJLBroadbentVReyGMcClainKLJanka-SchaubGEgelerRM. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society? Late Effects Study Group. Pediatric Blood and Cancer 2004 42 438444. (https://doi.org/10.1002/pbc.20021)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42

    MakrasPSamaraCAntoniouMZetosAPapadogiasDNikolakopoulouZAndreakosEToloumisGKontogeorgosGPiaditisG Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 2006 48 3744. (https://doi.org/10.1007/s00234-005-0011-x)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    VaianiEMalossettiCVegaLMZubizarretaPBraierJBelgoroskyA. Predictor variables of developing anterior pituitary deficiencies in a group of paediatric patients with central diabetes insipidus and Langerhans cell histiocytosis. Hormone Research in Paediatrics 2017 87 5157. (https://doi.org/10.1159/000452996)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44

    GrimbergADiVallSAPolychronakosCAllenDBCohenLEQuintosJBRossiWCFeudtnerCMuradMH & Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Hormone Research in Paediatrics 2016 86 361397. (https://doi.org/10.1159/000452150)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45

    LollarKFarragTYCaoDNiparkoJTufanoRP. Langerhans cell histiocytosis of the thyroid gland. American Journal of Otolaryngology 2008 29 201204. (https://doi.org/10.1016/j.amjoto.2007.05.004)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    BehrensRJLeviAWWestraWHDuttaDCooperDS. Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature. Thyroid 2001 11 697705. (https://doi.org/10.1089/105072501750362781)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Foulet-RogeAJosselinNGuyetantSGardetJJBescanconASaint-AndreJPFabianiB. Incidental Langerhans cell histiocytosis of thyroid: case report and review of the literature. Endocrine Pathology 2002 13 227233. (https://doi.org/10.1385/EP:13:3:227)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    MazziottiGFraraSGiustinaA. Pituitary diseases and bone. Endocrine Reviews 2018 39 440488. (https://doi.org/10.1210/er.2018-00005)

  • 49

    SatohTSmithASardeALuHCMianSTrouilletCMuftiGEmileJFFraternaliFDonadieuJ B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS ONE 2012 7 e33891. (https://doi.org/10.1371/journal.pone.0033891)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50

    SahmFCapperDPreusserMMeyerJStenzingerALasitschkaFBerghoffASHabelASchneiderMKulozikA BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 2012 120 e28e34. (https://doi.org/10.1182/blood-2012-06-429597)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51

    Badalian-VeryGVergilioJADegarBAMacConaillLEBrandnerBCalicchioMLKuoFCLigonAHStevensonKEKehoeSM Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010 116 19191923. (https://doi.org/10.1182/blood-2010-04-279083)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

PubMed

Google Scholar